Linlin Qu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Linlin Qu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Liang He
Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Jilin University, Changchun, China
2 shared publications Ruibo Liu
Department of Genetics and Prenatal Diagnosis, Hainan Women and Children’s Medical Center, Haikou, China
2 shared publicationsYuwen Huang
Department of Laboratory Medicine, The First Hospital of Jilin University, Jilin University, Changchun, China
2 shared publicationsFan Zhang
Department of Gastroenterology, The First Hospital of Jilin University, Changchun 130021, Jilin, China
1 shared publicationHuihui Shao
Department of Laboratory Medicine, The First Hospital of Jilin University, Jilin University, Changchun, China
1 shared publicationKening Chai
First Hosp Jilin Univ, Dept Lab Med, Changchun, Peoples R China
1 shared publication
Latest Publications
- Open Access
- 25 August 2026
- Published by Springer Nature in BMC Cancer
The potential of platelet TGF-β and Smad2 mRNAs as biomarkers for colon cancer diagnosis and grading
- 25 August 2026
- Published by Springer Nature in BMC Cancer
Open AccessThe potential of platelet TGF-β and Smad2 mRNAs as biomarkers for colon cancer diagnosis and grading
- Open Access
- 1 December 2022
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (12) , 1920-1927
Elevated serum AST and LDH levels are associated with infant death in premature babies with neonatal leukemoid reaction: a cohort study
Background: Neonatal leukemoid reaction (NLR) is often accompanied by infectious or non-infectious diseases, a low birth weight, sepsis, prematurity, ventricular hemorrhage, and bronchial dysplasia. It has an incidence rate of 1.3–15% and a mortality rate of about 41.4%. Previous studies on NLR have largely focused on its pathogenesis and clinical cases, but little is known about its prognostic laboratory indicators. We found that some of the NLR exhibited obviously elevation in liver function tests like aspartate transaminase (AST) and lactate dehydrogenase (LDH) which were not took by all the LR infants. The necessity for liver function tests for the prognosis of NLR was still unclear. Methods: A total of 39 premature infants with NLR at the First Hospital of Jilin University between March 2016 and March 2017 were included in this retrospective cohort study. The infants were divided into death and cured group based on the clinical outcomes. Premature infants with LR and death were defined as the case group (n=14), while infants without death were defined as the control group (n=25). Confounding factors such as age and gender between the two groups were controlled. Blood routine tests, including the white blood cell (WBC) count and subtypes, and liver function, and clinical features were recorded and analyzed. T tests were used to examine the differences in the laboratory indicators between the NLR and control groups. Receiver operating characteristic curves (ROCs) and areas under the curve (AUCs) were used to examine laboratory indicators for prognosis. Results: For predicting clinical outcomes, the ROC curves showed that the cut-off values for AST and LDH were 279 and 1,412 U/L, respectively. The sensitivity and specificity for AST were 92% and 71.43%, respectively, with an AUC of 0.894, while the sensitivity and specificity for LDH were 88% and 78.57%, respectively, with an AUC of 0.911. Conclusions: This innovative study investigated the NLR prognosis depending on laboratory tests. We found that serum AST and LDH levels had reliable predictive value in determining adverse outcomes of NLR.
- 1 December 2022
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (12) , 1920-1927
Open AccessElevated serum AST and LDH levels are associated with infant death in premature babies with neonatal leukemoid reaction: a cohort study
Background: Neonatal leukemoid reaction (NLR) is often accompanied by infectious or non-infectious diseases, a low birth weight, sepsis, prematurity, ventricular hemorrhage, and bronchial dysplasia. It has an incidence rate of 1.3–15% and a mortality rate of about 41.4%. Previous studies on NLR have largely focused on its pathogenesis and clinical cases, but little is known about its prognostic laboratory indicators. We found that some of the NLR exhibited obviously elevation in liver function tests like aspartate transaminase (AST) and lactate dehydrogenase (LDH) which were not took by all the LR infants. The necessity for liver function tests for the prognosis of NLR was still unclear. Methods: A total of 39 premature infants with NLR at the First Hospital of Jilin University between March 2016 and March 2017 were included in this retrospective cohort study. The infants were divided into death and cured group based on the clinical outcomes. Premature infants with LR and death were defined as the case group (n=14), while infants without death were defined as the control group (n=25). Confounding factors such as age and gender between the two groups were controlled. Blood routine tests, including the white blood cell (WBC) count and subtypes, and liver function, and clinical features were recorded and analyzed. T tests were used to examine the differences in the laboratory indicators between the NLR and control groups. Receiver operating characteristic curves (ROCs) and areas under the curve (AUCs) were used to examine laboratory indicators for prognosis. Results: For predicting clinical outcomes, the ROC curves showed that the cut-off values for AST and LDH were 279 and 1,412 U/L, respectively. The sensitivity and specificity for AST were 92% and 71.43%, respectively, with an AUC of 0.894, while the sensitivity and specificity for LDH were 88% and 78.57%, respectively, with an AUC of 0.911. Conclusions: This innovative study investigated the NLR prognosis depending on laboratory tests. We found that serum AST and LDH levels had reliable predictive value in determining adverse outcomes of NLR.
- Open Access
- 1 March 2021
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 20, 607-624
The lncRNA DLGAP1-AS1/miR-149-5p/TGFB2 axis contributes to colorectal cancer progression and 5-FU resistance by regulating smad2 pathway
- 1 March 2021
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 20, 607-624
Open AccessThe lncRNA DLGAP1-AS1/miR-149-5p/TGFB2 axis contributes to colorectal cancer progression and 5-FU resistance by regulating smad2 pathway